Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

A Enjuanes, R Albero, G Clot, A Navarro… - … journal of cancer, 2013 - Wiley Online Library
Mantle cell lymphoma (MCL) is a B‐cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …
被引用次数：22 相关文章
[HTML] nih.gov

[HTML][HTML] Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological …

A Enjuanes, R Albero, G Clot, A Navarro… - … journal of cancer, 2013 - ncbi.nlm.nih.gov
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.

A Enjuanes, R Albero, G Clot… - … Journal of Cancer, 2013 - search.ebscohost.com
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

A Enjuanes, R Albero, G Clot… - … journal of cancer, 2013 - pubmed.ncbi.nlm.nih.gov
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

A Enjuanes, R Albero, G Clot… - … Journal of Cancer, 2013 - ohsu.elsevierpure.com
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.

A Enjuanes, R Albero, G Clot, A Navarro… - … Journal of Cancer, 2013 - europepmc.org
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

A Enjuanes, R Albero, G Clot… - … Journal of Cancer, 2013 - mayoclinic.elsevierpure.com
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

A Enjuanes, R Albero, G Clot, A Navarro, S Beà… - International Journal of …, 2013 - infona.pl
Mantle cell lymphoma (MCL) is a B‐cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

[引用][C] Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological …

A ENJUANES, R ALBERO, L RIMSZA… - … journal of cancer …, 2013 - pascal-francis.inist.fr
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high
number of methylated CpGs and aggressive clinicopathological features CNRS Inist Pascal-Francis …

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

A Enjuanes, R Albero, G Clot… - … Journal of Cancer, 2013 - experts.nebraska.edu
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …